drugset / Trial / NCT02532660

Study to Evaluate the Efficacy of LABCAT TCJUSS in Patients With Depressive Episode

NCT02532660

RandomizedParallel-groupTriple-blindTreatment

Summary

Evaluate the therapeutic effects of Escitalopram versus an association of Escitalopram + Trichilia catigua Dry Extract (LABCAT TCJUSS) in the average alteration on depression score measured by the Hamilton Scale (HAM-D).

Timeline

Start
2018-07-02
Primary completion
2022-06-01
Completion
2022-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 10 mg
Subject LABCAT TCJUSS Unknown 1000 mg

Indications